To draw up the right dosage, we recommend choosing insulin-type syringes with markings of U-100 on the side
Important Disclaimer This product is intended strictly for laboratory research purposes only
A 2015 study by Gao et al
159 Patients were recruited, with a 26 week follow up
Sucic et al., 2019), and in particular, BPC 157 consistently decreased elevated MDA values, while MDA itself, owing to its high cytotoxicity and inhibitory action on protective enzymes, is suggested to act as a tumor promoter and a cocarcinogenic agent (Seven et al., 1999
The choice depends on (1) the per-research-unit amount specified in the research protocol, (2) preference for syringe increment precision, (3) the peptide's solubility characteristics, and (4) how quickly the reconstituted vial will be used (lower volumes concentrate more research doses in a smaller volume of reconstituted solution)